ArticleMycopathologia2026
Ergosterol-Dependent Membrane Stress and Calcineurin-HSP90 Signaling Govern Fluorinated Sulfone-Induced Cell Death in Candida albicans.
Article in Mycopathologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The antifungal activity of halogenated methyl sulfones depends on both the type and number of halogen atoms in the halogenomethylsulfonyl moiety. In this study, 28 halogenomethylphenyl sulfones were evaluated for minimal inhibitory (MIC) and fungicidal concentrations (MFC) against Candida albicans. Active compounds were further tested for cytotoxicity in vitro using the Vero E6 cell line. Notably, 4-(4-chloro-3,4-dichlorophenoxy)-2-nitrophenyl difluoromethyl sulfone (compound 15) showed fungicidal activity while remaining non-toxic at effective doses. Additionally, no adverse effects were observed in Galleria mellonella larvae treated with 15 in vivo. Mechanistic studies with 15 at a sub-inhibitory concentration (2 μg/mL) showed predominant induction of necrosis in C. albicans cells (88.43%) and protoplasts (96.25%), along with increased reactive oxygen species (ROS) production (31.17%). Cell cycle analysis revealed arrest in the G0 phase (99%), consistent with a pro-necrotic mechanism. RT-qPCR indicated that HSP90 gene expression contributes to C. albicans resistance to 15. Confocal microscopy confirmed the compound's fungicidal activity against planktonic and sessile C. albicans cells in vitro. Modulation experiments with exogenous ergosterol showed that reducing sterol concentrations decreased MIC values, suggesting that the fungal cell membrane is the primary target of 15 and that its interaction with ergosterol is critical for activity. Overall, 15 demonstrated antifungal activity comparable to that of amphotericin B and is a promising lead candidate for the development of new antifungal agents for local and systemic candidiasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.